{"title": "Find a Doctor", "author": null, "url": "https://www.dana-farber.org/find-a-doctor/judy-e-garber/", "hostname": "dana-farber.org", "description": "Judy E. Garber, MD, MPH - Medical Oncology. Dr. Garber is the Director of the Center for Cancer Genetics and Prevention at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School. She conducts research in clinical cancer genetics, with a special focus in the genetics of breast cancer. She has played a major role in the devel...", "sitename": "Judy E. Garber, MD, MPH - Dana-Farber Cancer Institute", "date": "2013-10-22", "cleaned_text": "Relations among symptoms of depression over time in at-risk youth. J Psychopathol Clin Sci. 2023 Jul 20. View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37471023) Adjuvant for Germline BRCA Carriers With HER2-Negative Cancer: 2023 28(7):565-574. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37210568) Correction to: Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. Breast Cancer Res Treat. 2023 Jul; 200(1):73. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37178433) Racial/ethnic differences in parenting Fam Psychol. 2023 Sep; 37(6):763-773. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37358525) Identification of mutation female carriers using circulating microRNA profiles. Nat Commun. 2023 Jun 08; 14(1):3350. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37291133) Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ. Res 16(6):333-341. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37259799) variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. Breast Cancer Res Treat. 2023 Jul; 200(1):63-72. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36856935) Results of a randomized controlled trial of a decision support intervention for disclosing maternal BRCA genetic test results to children and adolescents. PEC Innov. 2023 Dec; 2:100129. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37214493) Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Precis Oncol. 2022 Nov; 6:e2200084. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36331239) Summary of the experiences, knowledge, medical management, and family communication of monoallelic MUTYH carriers. J Genet [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36245263) ASO Visual Abstract: Screening MRI Does Not Increase Cancer Detection or Result in Earlier Stage at Diagnosis in Patients with High-Risk Breast Lesions-A Propensity Score Analysis. Ann Surg Oncol. 2022 Oct 12. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36222934) Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early Biol. 2022 10 06; 5(1):1061. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36203093) Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared Oct; 24(10):2208. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36205748) Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis. Ann Surg Oncol. 2022 Sep 28. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36171529) Twenty-year Outcomes of a Pediatric Chronic Abdominal Pain Cohort: Early Adulthood Health Status and Offspring Physical and Behavioral Health. J Pain. 2023 01; 24(1):145-156. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36126817) Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genes. Front Oncol. 2022; 12:942741. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36091175) Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk of Genetic Counseling on Patient-Reported Electronic Cancer Collection. Among Adolescent and Young Adult Children to Familial Cancer Risk. Pediatrics. 2022 08 01; 150(2). View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35859209) Trajectories of positive and negative affect across adolescence: Maternal history of depression and adolescent sex as predictors. J Affect Disord. 2022 10 15; 315:96-104. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35878831) Effects of depression prevention on anxiety through 18-month follow-up: A randomized [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35816916) for breast ATM, pathogenicity of VHL germline variants in patients suspected with von Hippel-Lindau syndrome: BRCA1, and PALB2 in [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35617956) The Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33): A Guide. of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines. JAMA risk modeling for prediction of epithelial ovarian cancer risk. Eur J Hum Genet. 2022 Breast Cancer. 2022 Apr 08; 8(1):47. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35396508) Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen. Breast [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35378642) Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition. Cancer Med. 2022 04; in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35092529) Polygenic risk modeling for prediction of epithelial ovarian cancer risk. Eur J Hum Genet. 2022 03; 30(3):349-362. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35027648) Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics. Cancer. 2022 03 15; 128(6):1275-1283. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34875721) Targeted Ashkenazi Jewish individuals using a web-enabled medical model: An observational study. Genet von Hippel-Lindau: from integrating somatic and germline 81(3):243-250. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34863587) Analysis Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database JAMA Oncol. 2021 Dec 01; 7(12):1800-1805. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34709361) Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared genetic counseling for hereditary cancer risk: Patient predictors of differential outcomes. and BRCA2 mutation status in a prospective cohort of young women with breast cancer. Br J Cancer. 2022 02; 126(2):302-309. View An integrated evaluation of germline 64(12):104359. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34628056) Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study. Med. 2021 10 07; 385(15):1440. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34614338) clinical and effects variants syndrome. Blood. 2021 09 09; 138(10):898-911. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34019641) Does Quantitative Sensory Testing Improve Prediction of Chronic Pain Trajectories? A Longitudinal Study of Youth With Functional Abdominal Pain Participating in a Randomized Controlled Trial of Cognitive Behavioral Treatment. Clin J Pain. 2021 09 01; 37(9):648-656. View in: II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations. Breast Cancer Res Treat. 2021 Oct; 189(3):641-651. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34417675) Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR Study. J Gen Intern Med. 2022 06; 37(8):1862-1869. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34173196) Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick 06; 5. of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nat Commun. 2021 May 14; 12(1):2986. View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33990587) The D Mammographic Density: Results from CALGB 70806 (Alliance) Cell 03 30; 34(13):108926. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33789101) A case-only study identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nat Commun. 2021 02 17; 12(1):1078. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33597508) Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing. JCO Precis Oncol. 2021; 5. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34036224) Unexpected Pathogenic RET p.V804M Variant Leads to the Clinical Diagnosis and Management of Medullary Thyroid Carcinoma. Am J Case Rep. 2020 Dec 27; View in: 01; 2(1):66-82. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33738458) Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D. J Adenomatous Polyposis Coli (APC) Gene, p.S2627Gfs*12 Identified in a Mild Phenotype of APC-Associated Polyposis: A Case Report. Am J Case Rep. 2020 Dec 11; 21:e927293. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33303731) Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer. Clin Cancer Res. 2021 02 15; 27(4):967-974. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33272980) Subgroups of Pediatric Patients With Functional Abdominal Pain: Replication, Parental Characteristics, and Health Service Use. Clin J Pain. 2020 12; 36(12):897-906. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32969866) Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer. Gynecol Oncol. 2021 Controlled Trial to Optimize Effects Through Risk-Informed J (ADP-Ribose) Polymerase Inhibitor Activity in Prostate Cancers Harboring Mutations in DNA Repair Genes: Who Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes. J Oncol. 2020 [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33119476) 'Case of the Month' from Brigham and Women's Hospital, Boston, MA, USA: a 70-year-old man with lung cysts and bilateral renal masses. BJU Int. 2020 10; 126(4):428-432. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33025754) Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer. NPJ Breast Cancer. 2020 Sep 10; 6(1):44. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/34504104) Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer. NPJ Breast Cancer. 2020; 6:44. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32964118) Informing models of cancer genetics care in the era of multigene panel testing with patient-led 30(1):268-282. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32851753) Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary Cancers. JCO Precis Oncol. 2020; 4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32954205) A pedigree-based prediction model identifies carriers of deleterious de novo mutations in families with Li-Fraumeni syndrome. Genome Res. 2020 08; 30(8):1170-1180. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32817165) Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: a study within a trial. BMC Med Res Methodol. 2020 08 17; 20(1):210. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32807084) Risk for breast cancer and management of unaffected individuals with non-BRCA hereditary breast cancer. Breast J. 2020 08; 26(8):1528-1534. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32741080) A Rare TP53 Mutation Predominant in Ashkenazi Jews Confers Risk of Multiple Cancers. Cancer Res. 2020 09 01; 80(17):3732-3744. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32675277) Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants. Genet Med. 2020 10; 22(10):1653-1666. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32665703) Effects of an adolescent depression prevention program on maternal criticisms and positive remarks. J Fam Psychol. 2020 Dec; 34(8):927-937. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32658515) 03; 34(3):542-548. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32636452) Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes. JAMA Netw Open. 2020 07 01; 3(7):e208501. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32609350) Comorbid Sleep Disturbance in Adolescents Functional Abdominal Behav Sleep Med. 2021 Jul-Aug; 19(4):471-480. View in: phenotype for germline TP53 variant classification 41(9):1555-1562. View in: to 08 10; 38(23):2700-2701. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32516090) Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk. JCO Precis Oncol. 2020; 4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32923876) Retinoblastoma and its predictors in triple-negative breast cancer. NPJ Breast Cancer. 2020 Jun 05; 6(1):19. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33579981) Retinoblastoma protein expression and its in triple-negative modulator of stalled fork stability in BRCA2-deficient cells. J 2020 06 01; 219(6). View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32391871) Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast Cancer. Cancer Prev Res (Phila). 2020 07; 13(7):623-634. Risk: A Case-Control Analysis Nested within the Nurses' Health Study from normal and cancer-prone human breast tissues preserve complex epithelial lineages. Nat Commun. 2020 04 06; Coordinating Center: Building an Interactive Web-Based Resource for Collaborative International Cancer Epidemiology Research for a Rare Condition. Cancer Biomarkers Prev. 2020 05; 29(5):927-935. View in: in Germline BRCA Carriers With HER2-Negative 10; 38(14):1539-1548. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32097092) Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nat Genet. 2020 01; 52(1):56-73. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31911677) Prevalence of cancer in carcinoma. Genet Med. 2020 04; Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Oncol. Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis. Clin Cancer View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31796517) FANCM:p.Arg658* truncating associated with risk of triple-negative breast cancer. NPJ Breast Cancer. 2019; 5:38. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31700994) Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers. Cancer. 2020 01 15; 126(2):271-280. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31581314) One step forward, two Med. 02; 22(2):441-442. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31578472) Publisher Correction: Shared heritability and functional enrichment across six solid cancers. Nat Commun. 2019 Sep 23; 10(1):4386. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31548585) Li-Fraumeni a anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31533767) Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ. Nat Commun. 2019 09 13; 10(1):4182. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31519911) Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update. J Clin Oncol. 20; 37(33):3152-3165. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31479306) Incidental breast carcinoma: incidence, management, and outcomes in 4804 bilateral reduction mammoplasties. Breast Cancer Res Treat. 2019 Oct; View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31317348) BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry. Hum Mutat. 2019 10; 40(10):1781-1796. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31112363) Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations. Breast J. 2019 07; 25(4):575-577. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31280501) Genetic Testing for Breast Cancer Susceptibility Should Be Offered before Unilateral Abdominally Based Free Flap Breast Reconstruction. of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers. Br J Cancer. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31213659) in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31110002) Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nat Commun. 2019 04 15; 10(1):1741. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30988301) Development and testing of the KnowGene scale to assess general cancer genetic knowledge related to multigene panel testing. Patient Educ Couns. 2019 08; 102(8):1558-1564. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31010603) Developing a Novel Model to Improve Research and care for Cancer Survivors: a Feasibility Study. J Cancer Educ. 2019 04; 34(2):229-233. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29052110) Prevalence of germline in cancer. Cancer. 2019 07 01; 125(13):2194-2202. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30933323) Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30312457) Medical and Psychosocial Experiences After Detection of Variant With Multigene Testing. JCO Precis View in: effect content and tone of maternal evaluative feedback on self-cognitions and affect in young children. J Child Psychol. 2019 06; 182:151-165. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30826468) County-level socioeconomic and crime risk factors for substantiated child abuse and neglect. Child Abuse Negl. 2019 04; 90:127-138. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30776738) Shared heritability and functional enrichment across six solid cancers. Nat Commun. 2019 01 25; 10(1):431. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30683880) Trans-counseling: A case series of transgender individuals at high risk for BRCA1 pathogenic gynecomastia: what is their breast cancer risk? Breast Cancer Res Treat. 2019 May; 175(1):1-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30666539) Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at risk. Breast Cancer Res Treat. 2019 May; 175(1):229-237. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30666540) Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS). in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30586411) Breast Cancer Surgical Risk Reduction for Patients With Inherited Mutations in Moderate Penetrance Genes. JAMA Surg. 2018 12 01; 153(12):1145-1146. View Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Practice Guidelines Interpersonal Vulnerabilities to Adolescent Depression: Classification of Risk Profiles for a Personalized Prevention Approach. J Abnorm Child Psychol. 2018 10; 46(7):1521-1533. View for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2018 Oct 01; 29(10):2153. View BRCA-Mutated Unselected Metastatic Advanced Breast Cancer in reduction mammoplasty specimens: a surrogate for the population prevalence of breast cancer and high-risk lesions. Breast Cancer Res Treat. 2019 Jan; 173(1):201-207. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30238276) Mixing Mutation Location With Carcinogen Exposure: A Recipe for Tissue Specificity in BRCA2-Associated Cancers? J [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29767746) Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing. J Natl Cancer Inst. 2018 08 01; 110(8):855-862. View in: in Mutation Emerge From Testing. J 01; in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29529297) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res. 2018 09 15; 78(18):5419-5430. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30054336) Precision Prevention and Early Detection of Cancer: Fundamental Discov. 2018 07; 8(7):803-811. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29907587) BRCA1/2 testing: therapeutic implications for breast cancer management. Br J Cancer. 2018 07; 119(2):141-152. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29867226) Validating parent and child forms of the Parent Perception Inventory. Psychol Assess. 2018 08; 30(8):1065-1081. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29683689) Towards Prevention of Breast Cancer: What Are the Clinical Challenges? Cancer Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers. 2018 05 15; 78(10):2747-2759. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29559475) Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat. 2018 05; [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29446198) counseling framework [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29493579) A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease. Cancer Prev Res (Phila). 2018 04; 11(4):203-214. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29453232) Prevention Depression in At-Risk of Prev Sci. 1):6-15. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26830893) Social learning pathways in the relation between parental chronic pain and daily pain severity and functional impairment in adolescents with functional abdominal pain. Pain. 2018 02; 159(2):298-305. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29016461) Pollen-food allergy syndrome is a allergic comorbidity in adults with eosinophilic esophagitis. Dis Esophagus. Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al. Ann Oncol. patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II 2018 01; 29(1):154-161. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29045554) Baseline Surveillance [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28772291) A comparison of cancer risk assessment and testing outcomes in patients from underserved vs. tertiary care settings. J Community Genet. 2018 Jul; 9(3):233-241. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29151150) Judy Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk. NPJ Breast Cancer. 2017; 3:44. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29119134) Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study. Pediatr Blood Cancer. 2018 Feb; 65(2). View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29077256) Identification of ten variants associated of cancer. Nat Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients. Clin Cancer Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2017 08 01; 28(8):1700-1712. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28838210) Interacting influences of gender and chronic pain status on parasympathetically mediated heart rate variability in adolescents and young adults. Pain. 2017 08; 158(8):1509-1516. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28715351) Patient experience with breast reconstruction process following bilateral mastectomy in BRCA mutation carriers. Am J Surg. 2017 Oct; 214(4):687-694. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28683895) Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition. Cancer Discov. 2017 10; and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer. Cancer. 2017 Sep 15; 123(18):3532-3539. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28608931) The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk. NPJ Breast Cancer. 2017; 3:22. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28649662) Reassessing risk models for atypical hyperplasia: age may not matter. Breast Cancer Res Treat. 2017 Sep; 165(2):285-291. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28589368) Cancer Screening Recommendations Res. 2017 06 01; 23(11):e38-e45. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28572266) Managing hereditary breast cancer risk in women with and without ovarian cancer. Gynecol Oncol. 2017 07; 146(1):205-214. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28454658) Cancer Res. 2017 04 01; 77(7):1510-1541. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28373404) Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. May; 49(5):680-691. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28346442) Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study. J Clin Oncol. 2017 Apr somatic and germ-line whole-exome sequencing data in a prospective cancer world of precision medicine: deliberations of a precision medicine tumor board. Per Med. 2017 Jan; 14(1):37-50. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28757884) Community-level moderators of a assault Child Abuse Negl. 2017 Jan; 63:295-306. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27890344) Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer Res. 2016 11 11; 18(1):112. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27836010) Using machine learning to parse breast pathology reports. Breast Cancer Res Treat. 2017 01; 161(2):203-211. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27826755) Uterine Reply Sorscher Clin Oncol. 2016 12; 34(34):4187-4188. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27551137) Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. Breast Cancer Treat. 2017 01; 161(1):117-134. A veliparib with or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27739325) Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Breast Cancer Res Treat. 2016 12; 160(3):393-410. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27734215) Treatment and Prevention of Depression and Anxiety in Youth: Test of Cross-Over Effects. Depress Anxiety. 2016 10; 33(10):939-959. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27699941) Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing. J Clin Oncol. 2016 prevention. Proc Acad Sci S A. 2016 09 27; View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27638202) Functional mechanisms underlying the cancer Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. PLoS One. 2016; 11(7):e0158801. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27463617) The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine. Genome Med. 2016 07 26; 8(1):79. View 2016 45(10):1973-95. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27380467) Supplementation on Breast Cancer Biomarkers: CALGB 70806 (Alliance) Study Design and Baseline Data. Hematol Oncol. 2016 Jul; 12(7):4-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29081880) Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Breast [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27296296) BRCA1 and Testing in Young Women With Breast Cancer. JAMA Oncol. 2016 Jun 01; 2(6):730-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26867710) 2016 May 27; 352(6289):1052-3. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27230363) Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nat Commun. 2016 04 27; 7:11375. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27117709) Within-Person Changes in Individual Symptoms of Depression Predict Subsequent Depressive Episodes in Adolescents: a Prospective Study. J Abnorm Child Psychol. 2016 Apr; View in: with load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous cancer. Oncotarget. 2016 Mar 22; 7(12):13587-98. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26871470) Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. J Clin Oncol. 2016 May 01; 34(13):1460-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26976419) Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer. Clin Cancer Res. 2016 08 01; 22(15):3764-73. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26957554) Breast cancer risk variants different associations and androgen and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer. NPJ Breast Cancer. 2016; 2:16002. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28721372) The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk Women. Cancer (Phila). incidental findings: results from Med. 2016 10; 18(10):1011-9. View in: breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res. 2016 Feb 09; 18(1):15. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26857456) Genetic/Familial in At-Risk Adolescents: Predictors and Moderators of Acute Effects. J Am Child Adolesc Psychiatry. 2016 Mar; 55(3):219-26. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26903255) THE GORDON WILSON LECTURE EVOLUTION OF CLINICAL CANCER GENETICS. Trans Am Clin Climatol Assoc. 2016; 127:127-139. View in: in the Health Study. Cancer Epidemiol Biomarkers Prev. 2016 Jan; 25(1):201-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26762806) through Precision and Immune-oncology. Prev Res (Phila). 2016 Jan; 9(1):2-10. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26744449) Developmental Demands of Cognitive Behavioral Therapy for Depression in Children and Adolescents: Cognitive, Social, and Emotional Processes. Annu Cancer Clin 2016 Feb 20; 34(6):539-41. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26712228) A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst. 2016 Feb; 108(2). View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26586665) Effect of a Cognitive-Behavioral Prevention Program on Depression 6 Years After Implementation Among At-Risk Adolescents: A Randomized Clinical Trial. JAMA Psychiatry. 2015 Nov; in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26421861) Patient Perceptions Telephone Oct 01; 33(28):3092-5. View PARP inhibitors in the management of breast cancer: current data and future prospects. BMC Med. 2015 Aug 13; 13:188. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26268938) Breast Cancer Risk and Follow-up Recommendations for Young Women Diagnosed with Atypical Hyperplasia and Lobular Carcinoma In View JAMA. 2015 Jul 14; 314(2):162-9. View as a moderator of relations between cortisol and shame responses to social-evaluative threat in young adults. Biol Psychol. 2015 Jul; 109:159-65. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26048679) No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecol Oncol. 2016 05; 141(2):386-401. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25940428) Programs for the Prevention of Youth Depression: Evaluation of Efficacy, Effectiveness, and Readiness for Dissemination. J Clin Child Adolesc Psychol. 2016 Nov-Dec; identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Breast Cancer Res. 2015 Apr 25; 17:61. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25925750) Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA. 2015 Apr 07; 313(13):1347-61. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25849179) TBCRC009: A Phase II of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Jun View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25847936) Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation PLoS One. Apr; 125(4):1523-32. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25751062) Longitudinal relations between stress and depressive symptoms in youth: coping as a mediator. J Abnorm Child Psychol. 2015 Feb; 43(2):355-68. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24993312) Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nat Genet. 2015 Feb; 47(2):164-71. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25581431) Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. Dec 16(6):3416. in: mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Res. 2014 Dec 23; 16(6):3419. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25857409) The effects of psychological treatment of maternal depression on children and parental functioning: a meta-analysis. Eur Child Adolesc Psychiatry. 2015 Feb; 24(2):237-45. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25522839) Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Feb 01; 33(4):304-11. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25452441) BRCA1 for replication stress in primary Nat Commun. 2014 Nov 17; 5:5496. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25400221) Two prospective studies of changes in stress generation across depressive episodes in adolescents and emerging adults. Dev Psychopathol. 2014 Nov; 26(4 Pt 2):1385-400. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25422968) Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. individual depressive symptoms in adolescents: gender and family relationships as predictors. Dev Psychol. 2014 Dec; 50(12):2633-43. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25329553) Addressing dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention. J Sex Med. 2015 Jan; 12(1):189-97. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25311333) Use of risk-reducing prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2014 Nov; 148(2):397-406. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25311111) Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling. Genet Med. 2015 Jun; 17(6):467-75. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25232856) Parent decision-making around the genetic testing of children for germline TP53 mutations. Cancer. 2015 Jan 15; 121(2):286-93. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25223899) Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25186627) [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25190698) concerns about the emotional impact of awareness of heritable breast cancer risk and its implications for their children. J Community Genet. 2015 Jan; 6(1):55-62. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25099078) Executive function moderates the relation between coping and depressive symptoms. Anxiety Stress Coping. 2015; 28(1):31-49. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24866556) Germline TP53 mutations and Hum Mutat. 2014 Jun; 35(6):654-62. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24706533) Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers. Breast Cancer Res Treat. 2014 Jul; 146(1):175-82. View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24839033) Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med. 2014 Jun; 20(6):682-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24836576) Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling. Psychooncology. 2015 Jan; 24(1):33-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24839250) Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors. Ann Oncol. 2014 Aug; 25(8):1656-63. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24827126) Predicting persistence of functional abdominal pain from childhood into young adulthood. Clin Gastroenterol Hepatol. 2014 Dec; 12(12):2026-32. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24732284) DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation a germinal mutation of the KIT gene in an Argentine family. Acta Gastroenterol Latinoam. 2014 Mar; 44(1):9-15. View in: with breast cancer rearrangements in BRCA1 and BRCA2. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol. 2014 Mar 01; 32(7):618-26. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24449235) Interactive models of depression vulnerability: the role of childhood trauma, dysfunctional attitudes, and coping. Br J Clin Psychol. 2014 Jun; 53(2):245-63. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24372468) adnexal neoplasia during risk reduction salpingo-oophorectomy in women and BRCA2 mutation carriers: results from a follow-up study. Br J Cancer. 2014 Jan 21; 110(2):530-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24292448) Prevention of 2013 Nov; 70(11):1161-70. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24005242) Functional abdominal pain in childhood and long-term vulnerability to anxiety disorders. Pediatrics. 2013 Sep; 132(3):475-82. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23940244) Dynamic temporal relations between anxious and depressive symptoms across adolescence. Dev Psychopathol. 2013 Aug; 25(3):683-97. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23880385) Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Oncol. 2013 Aug 10; 31(23):2942-62. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23835710) Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children. Cancer Epidemiol Biomarkers Prev. 2013 Jul; 22(7):1260-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23825307) Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners. Health Psychol. 2014 Aug; 33(8):765-73. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23795707) Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell. 2013 Jul 03; 13(1):117-30. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23770079) Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J to experimentally manipulated psychosocial stress in young adults at varied risk for depression. Depress Anxiety. 2014 Jan; 31(1):44-52. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23606237) Prevalence of germline TP53 mutations in HER2+ breast cancer patients. Breast Cancer Res Treat. 2013 May; 139(1):193-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23580068) Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013 Apr; 45(4):371-84, 384e1-2. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23535731) in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet. 2013; 9(3):e1003212. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23544013) A randomized controlled trial of a cognitive-behavioral program for the prevention of depression in adolescents compared with nonspecific and no-intervention control conditions. J Couns Psychol. 2013 Jul; [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23506514) Multiplex genetic testing for cancer susceptibility: out on the high wire without a net? J Clin Oncol. 2013 Apr 01; 31(10):1267-70. Young adult daughters of BRCA1/2 positive mothers: what do they know about hereditary cancer and how much do they worry? Psychooncology. 2013 Sep; 22(9):2024-31. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23417902) Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapy. J Am Adolesc Psychiatry. 2013 Feb; View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23357439) The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat. 2012 Dec; 136(3):627-33. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/23117858) Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice. J Genet Couns. 2013 Jun; 22(3):303-14. View in: cancer in BRCA1 mutation carriers: comparison between common Ashkenazi Jewish and other mutations. J Oncol. 2012 mutation in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22613997) Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium. Cancer Genet. 2012 Oct; 205(10):479-87. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22939227) Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome. Gynecol Oncol. 2012 Dec; 127(3):544-51. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22940489) Translating basic psychopathology research to preventive interventions: a tribute to john R. Z. Abela. predict depression trajectories: social-evaluative threat and prior depressive episodes as moderators. J Affect Disord. 2012 Dec 20; 143(1-3):223-30. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22858210) The feasibility of using natural language processing to extract clinical information from breast pathology reports. J Pathol Inform. 2012; 3:23. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22934236) A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Prev. 2012 in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22729394) pain patient subtypes in childhood predict functional gastrointestinal disorders with chronic pain and psychiatric comorbidities in adolescence and adulthood. Pain. 2012 Sep; 153(9):1798-1806. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22721910) Mutational processes molding the genomes of 21 breast cancers. Cell. 2012 May 25; 149(5):979-93. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22608084) Evolutionary in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22628410) Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents. Cancer Discov. 2012 Apr; 2(4):366-375. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22576213) Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. J Clin Oncol. 2012 Apr 20; 30(12):1321-8. TP53 germline mutations: a Li-Fraumeni syndrome consortium effort. Breast Cancer Res Treat. 2012 Jun; 133(3):1125-30. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22392042) Relations among posttraumatic stress disorder, comorbid major depression, HPA function: a review to early puberty, sexual debut, and sexual risk taking: tests of an integrated evolutionary-developmental model. Dev Psychol. 2012 May; 48(3):687-702. View in: characteristics and of cancer: survival. Cancer Genet. 2012 Jan-Feb; 205(1-2):34-41. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22429596) Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of of Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children. Genet Test Mol study of simvastatin in women at increased risk of a new breast cancer. Breast Cancer Res Treat. 2012 Feb; 131(3):915-24. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22076478) Predictors of the first onset of a major depressive episode and changes in depressive symptoms across adolescence: stress and negative cognitions. J Abnorm Psychol. 2011 Nov; 120(4):779-96. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21928863) Challenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancer. J 10; kidney angiomyolipomas and other tumors decrease. PLoS One. 2011; 6(9):e23379. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21915260) Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome. Fam Cancer. 2011 Sep; 10(3):549-56. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21567236) Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. Cancer Res. 2011 Sep 01; 71(17):5792-805. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21799032) Gastric cancer in individuals Genet Med. 2011 Jul; 13(7):651-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21552135) Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 prevention 2011 23; 364(25):2381-91. in: mutations 2011 Jun; 10(2):225-31. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21365267) Stumbling blocks on the path to personalized medicine in breast cancer: the case of PARP inhibitors for BRCA1/2-associated cisplatin or carboplatin for metastatic triple-negative breast cancer and evaluation of p63/p73 as a biomarker of response. J Clin Oncol. 2011 May 20; 29(15_suppl):1025. BRCA1 (B1)- and BRCA2 carriers an increased risk of breast cancer? J Clin Oncol. 2011 May 20; 29(15_suppl):1501. View in: 20; 29(15_suppl):1519. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28023605) Prevalence of hereditary GIST susceptibility in adults with GIST. J Clin Oncol. 2011 May 20; 130(5):685-99. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21597964) Family cancer history: Inst. 2011 May 18; 103(10):776-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21562244) Structure and measurement of depression in youths: applying item response theory to clinical data. Psychol Assess. 2011 Dec; 23(4):819-33. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21534696) Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med. 2011 Apr; 13(4):349-55. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21358336) Attentional bias to pain and social threat in pediatric patients with functional abdominal pain and pain-free youth before and after performance evaluation. Pain. 2011 May; 152(5):1061-1067. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21420789) Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. Am J Psychiatry. 2011 Jun; 168(6):593-602. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21406462) Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers. 20(5):1032-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21393566) Targeting the missing links for cancer therapy. Nat Med. 2011 Mar; 17(3):283-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21383736) Early psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trial. Bipolar Disord. 2011 Feb; 13(1):67-75. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21320254) Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers. Cancer. 2011 Jul 15; 117(14):3093-100. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21264845) Time to think outside the (genetic) box. Cancer Prev Res (Phila). 2011 Jan; 4(1):6-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21205738) Remission of depression in parents: links to healthy functioning in their children. Child Dev. 2011 Jan-Feb; 82(1):226-43. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21291439) Comorbidity of Anxiety and Depression in Youth: Implications for Treatment and Prevention. Clin Psychol (New York). 2010 Dec; 17(4):293-306. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21499544) DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer. Clin Cancer Res. 2010 Dec 01; 16(23):5796-804. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21138871) Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers. Breast Cancer Res. 2010; 12(6):R95. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21080930) Intergenerational transmission of depression: a launch and grow model of change across adolescence. Dev Psychopathol. 2010 Nov; 22(4):819-30. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20883584) Dynamic associations between maternal depressive symptoms and adolescents' depressive and externalizing symptoms. J Abnorm Child 38(8):1069-81. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21060860) in women with early-onset or familial lobular breast cancers. J Med Genet. 2011 Jan; 48(1):64-8. 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet. 2010 Oct; 42(10):885-92. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20852631) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010 Sep 01; 304(9):967-75. reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled with or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet. 2010 Jul 24; 376(9737):235-44. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20609467) Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer. J Natl Cancer Inst. 2010 Jul 07; 102(13):942-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20554945) A prospective study of stress autonomy versus stress sensitization in adolescents at varied risk for depression. J Abnorm 2010 May; 119(2):341-54. View BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy. Breast Cancer Res Treat. 2010 Jun; 121(2):389-98. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20411323) Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal Oncol. 2010 Oct; 21(10):2107-2111. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20348145) Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis. 2010 Nov; 124(2):441-51. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20309627) Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers. Breast Cancer Res Treat. 2010 Nov; 124(1):195-203. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20180014) Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features. Breast Cancer Res. 2010; 12(1):R12. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20149218) in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20100965) Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat. 2010 Jan; 119(1):137-44. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19728082) The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube. J Pathol. 2010 Jan; 220(1):17-23. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19834951) Breast cancer prevention: patient decision making and risk communication in the high risk setting. Breast J. 2010 Jan-Feb; 16(1):38-47. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19889168) NCCN clinical practice guidelines in cancer diagnosis. J 2009 Nov; 7(10):1060-96. relation between depression and comorbid psychopathology in adolescents at varied risk for depression. J Child Psychol Psychiatry. 2010 Mar; 51(3):242-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19874429) Contralateral breast cancer in BRCA1/BRCA2 mutation carriers: the story of the other side. J Clin Oncol. 2009 Dec 10; 27(35):5862-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19858367) Prevalence and functional analysis of sequence variants in the ATR checkpoint mediator Claspin. View testing in young women with breast cancer: results from a Web-based survey. Ann Oncol. 2010 Apr; 21(4):741-747. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19713245) functional deficiency supports pathogenicity of BRCA1 p.V1688del. Cancer Res. 2009 Sep 01; 69(17):7030-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19706752) Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. Cancer Res. 2009 Sep 01; 69(17):7053-61. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19690142) Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer. Gynecol Oncol. 2009 Oct; 115(1):108-111. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19615727) Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together. Patient Educ Couns. 2010 Jan; 78(1):29-33. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19545972) Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. Cancer Res. 2009 69(14):5801-10. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19584272) Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers. Am J Surg Pathol. 2009 Jul; 33(7):1093-7. View in: the oral PARP inhibitor olaparib in BRCA-deficient advanced breast Jun 20; View in JAMA. 2009 Jun View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19491183) American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast risk Oncol. 2009 Jul 01; 27(19):3235-58. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19470930) Determination of factors predicting for estrogen receptor positive (ER+) breast cancers in BRCA1 mutation carriers. Clin Oncol. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27963985) Prevalence of CDH1 germline mutations in subjects with early onset or familial lobular breast cancer, a multicenter collaboration. bevacizumab in breast cancer (TNBC): Safety and efficacy. J Clin Oncol. 2009 May 20; 27(15_suppl):551. View in: of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast May 20; 27(15_suppl):CRA501. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27963470) Parental decisions and outcomes regarding disclosing maternal BRCA1 and 2 test results to children. J Clin Oncol. 2009 May 20; 27(15_suppl):9582. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27963706) Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization. J Gen Intern Med. 2009 Jul; 24(7):822-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19455369) Reproducibility of random periareolar fine needle aspiration in a multi-institutional Cancer and Leukemia Group B (CALGB) cross-sectional study. Res (Phila). 2(2):100-3. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19174575) Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast Cancer Res. 2009; 11(5):R76. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19843326) American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment. J Clin Oncol. Feb 20; 27(6):986-93. View in: cancer: risk factors potential targets. Res. 2008 Dec 15; 14(24):8010-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19088017) VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy. Clin View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19047116) Physicians' experiences with BRCA1/2 Oncol. 2008 Dec 10; 26(35):5789-96. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19001322) A prospective study of the cognitive-stress model of depressive symptoms in adolescents. J Abnorm Psychol. 2008 Nov; 117(4):719-34. View View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/19071253) Remission of maternal depression: relations to family functioning and youth internalizing and externalizing symptoms. J 2009 May; 34(4):430-40. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18782857) Course and Severity of Maternal Depression: Associations with Family Functioning and Child Adjustment. J Youth Adolesc. 2008 Sep; 37(8):906-916. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25013241) Risk factors for a serous cancer precursor (\"p53 signature\") in women with Nov; 111(2):226-32. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18718648) Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomy. Psychooncology. 2008 Aug; 17(8):831-43. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18636423) Rapid progression of prostate cancer in men with a BRCA2 mutation. Br J Cancer. 2008 Jul 22; 99(2):371-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18577985) Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study. Am J Psychiatry. 2008 Sep; 165(9):1136-47. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18558646) Outcomes following breast conservation versus mastectomy in BRCA1/2 carriers with early-stage breast cancer. J Clin Oncol. 2008 20; 26(15_suppl):536. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27948393) Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Attitudes 19; View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18349092) A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA 109(2):168-73. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18342932) Genome-wide association study provides evidence breast cancer risk locus at 6q22.33. Proc Natl Acad Sci in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18326623) Risk-reducing salpingo-oophorectomy gynecologic cancer: a 26(8):1331-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18268356) Research issues affecting preoperative systemic therapy for operable breast cancer. J Clin Oncol. 2008 Feb 10; 26(5):806-13. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18258990) Convergence among multiple methods of measuring positivity and negativity in the family environment: relation to depression in mothers and their children. J Fam Psychol. 2008 Feb; 22(1):123-34. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18266539) Time in breast Clin Oncol. 2008 01; 26(4):519-20. polymorphism associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Res. 2008 Jan 01; 68(1):22-5. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18172292) Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. Int J Cancer. 2007 Dec 15; 121(12):2661-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17721994) Current and past maternal depression, maternal interaction behaviors, and children's externalizing and internalizing symptoms. oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers. Clin Breast Cancer. 2007 Dec; 7(11):875-82. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/18269778) Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? J Surg [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17640031) A typology of pain coping strategies in pediatric patients with chronic abdominal pain. Pain. 2008 Jul 15; 137(2):266-275. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17928144) RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet. 2007 Dec; 81(6):1186-200. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17999359) Remission of maternal depression and child symptoms among single mothers: a STAR*D-Child report. Soc Psychiatry Psychiatr Epidemiol. 2007 Dec; View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17934684) Prevention symptoms in adolescents: a randomized trial of cognitive-behavioral and interpersonal prevention programs. Consult Clin Psychol. to mammogram implications Dec; 14(12):3352-8. View malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007 Sep 01; 25(25):3985-90. View in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17627006) Prospective relations between organized activity participation and psychopathology during adolescence. J Abnorm Child Psychol. 2007 rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United States. Clin Breast Cancer. 2007 Jun; 7(8):627-33. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17592676) Molecular definition of breast Cancer Cell. 2007 Mar; 11(3):259-73. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17349583) Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2007 Oct; 105(2):221-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17245541) Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children. Genet Test. 2007; 11(3):249-55. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17949286) Predicting school dropout and adolescent sexual behavior in offspring of depressed and nondepressed mothers. J Am Acad Child Adolesc Psychiatry. 2007 Jan; 46(1):15-24. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17195725) A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 2007 Jan; 211(1):26-35. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17117391) Ethical issues in cancer genetics: I 1) whose information is it? J Genet Couns. 2006 Dec; 15(6):491-503. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17106632) Depression in children and adolescents: linking risk research and prevention. Am J Prev Med. 2006 Dec; 31(6 Suppl 1):S104-25. View internalizing and externalizing symptoms in adolescents: a four-year View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16866584) Validation of a symptom provocation test for laboratory studies of abdominal pain and discomfort in children and adolescents. J Pediatr Psychol. 2006 Aug; 31(7):703-13. View Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial. J Natl Cancer Inst. 2006 Jul 05; 98(13):904-10. prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy. Am J Surg. 2006 Jul; 192(1):58-62. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16769276) Prevalence of BRCA1 mutations in triple negative breast cancer (BC). J Clin Oncol. 2006 Jun 20; 24(18_suppl):508. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27953622) of breast women with TP53 mutations. J Clin Oncol. 2006 in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27954107) Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons. Clin Breast Cancer. 2006 Jun; 7(2):158-61. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16800976) Trajectories of symptoms and impairment for pediatric patients with functional abdominal pain: a 5-year longitudinal study. J Am Acad Child Adolesc Psychiatry. 2006 Jun; 45(6):737-744. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16721324) The prevention of depressive symptoms in children and adolescents: A meta-analytic review. J Consult Clin Psychol. 2006 Jun; 74(3):401-15. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16822098) Appraisal and coping with daily stressors by pediatric patients with chronic abdominal pain. J Pediatr Psychol. 2007 Mar; 32(2):206-16. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16717138) The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members. J Clin Oncol. 2006 Jun 20; 24(18):2948-57. View 2006 May; 4(5):480-508. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16687096) The PRIME curriculum. Clinical research training during residency. J Gen Intern Med. 2006 May; 21(5):506-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16704399) breast 24(16):2437-43. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16636335) Frequent amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis. 2006 Apr 01; 66(7):3452-5. View in: Remissions in maternal depression JAMA. 2006 Mar 22; 295(12):1389-98. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16551710) Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. Breast Cancer Res. 2006; 8(2):R15. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16563180) Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective Lancet Oncol. 2006 Mar; 7(3):223-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16510331) Parent attention versus distraction: impact on symptom complaints by children with and without chronic functional abdominal pain. Pain. 2006 May; 122(1-2):43-52. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16495006) results with relatives: factors predicting who women tell. J Clin 01; 24(4):700-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16446344) fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006 Feb; 30(2):230-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16434898) Children depressed mothers: STAR*D ancillary J Clin Psychiatry. 2006 Jan; 67(1):126-36. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16426099) Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology. 2006 Jan; 130(1):73-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16401470) Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutations. Cancer loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues. J Clin Oncol. 2005 Dec 01; 23(34):8613-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16314623) The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. Carcinogenesis. 2006 Mar; 27(3):599-605. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16244359) Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer. Int J Radiat Oncol Biol Phys. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the Oncol. 2005 Nov 01; 23(31):7804-10. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16219936) Quality or quantity in the management of hereditary ovarian cancer risk: Is it really a trade-off? J Clin Oncol. 01; 23(28):6817-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16157931) Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Causes Control. 2005 Aug; 16(6):667-74. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16049805) The role of social stressors and interpersonal orientation in explaining the longitudinal relation between externalizing and depressive symptoms. J Abnorm Psychol. 2005 Aug; 114(3):432-43. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16117580) Sex ratio distortion in offspring of families with BRCA1 or BRCA2 mutant alleles: an ascertainment bias phenomenon? 2005 Aug; 92(3):273-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16155798) A HIF1alpha View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16103922) Testing a model of pain appraisal and coping in children with chronic abdominal pain. Health Psychol. 2005 Jul; 24(4):364-74. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16045372) Germline TP53 mutations in women with very early onset breast cancer (BR). J Clin Oncol. 2005 Jun; 23(16_suppl):1015. (FVL) mutations and thromboembolic events (TE) in women with breast cancer on adjuvant tamoxifen. J in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk. Cancer Epidemiol Clin Oncol. 2005 Apr 20; 23(12):2735-43. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/15837988) The relations among maternal depression, maternal criticism, and adolescents' externalizing and internalizing symptoms. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/15637391) Resting frontal brain activity: linkages to maternal depression and socio-economic status among adolescents. Biol Psychol. 2004 Oct; 67(1-2):77-102. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/15130526) Cancer prevention the American Society of Clinical Oncology. J Clin Oncol. 2004 Oct 01; 22(19):3848-51. View in: Breast-feeding the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer 21; 96(14):1094-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/15265971) A randomized trial of two different genetic counseling interventions for BRCA1/2 genetic testing. J Clin Oncol. 2004 Jul 15; study of in Hodgkin's (HD) survivors. 15; 22(14_suppl):8551. View in: BRCA1/2 test results to first-degree relatives (FDRs): Factors predicting who women tell. J 15; Clin Oncol. 2004 Jul 15; 22(14_suppl):9609. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28016186) Comparison of complementary medicine use at genetic testing program enrollment and one-year following results disclosure. J Clin Oncol. 2004 Jul 15; 22(14_suppl):1013. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28014606) in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/15245835) Comparison of motivations and concerns for genetic testing in hereditary colorectal and breast cancer syndromes. J Med Genet. 2004 Apr; 41(4):e44. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/15060120) Clinical presentation correlates with the type of mismatch repair gene involved in hereditary nonpolyposis colon cancer. Gastroenterology. 2004 Mar; 22(6):978-80. View in: Bilateral mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. Oncol. 2004 Mar 15; 22(6):1055-62. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/14981104) One less thing to worry about: the shrinking spectrum of tumors in BRCA founder mutation carriers. J Natl Cancer Inst. 2004 Jan 07; 96(1):2-3. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/14709725) Accuracy of cancer family histories: of two cancer syndromes. Genet Test. 2004; 8(3):222-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/15727243) Cancer variation associated with the position of the mutation in the BRCA2 gene. Fam Cancer. 2004; 3(1):1-10. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/15131399) Progress in the of gynecologic cancer: consensus statement. J 21(10 Suppl):129s-132s. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12743127) Relation of intelligence and religiosity to depressive disorders in offspring of depressed and nondepressed mothers. J Am Acad Child Adolesc Psychiatry. 2003 May; View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12707562) cancer Clin. 2003 May-Jun; 53(3):138-40. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12809407) Cancer surveillance is often inadequate in people at high risk for colorectal cancer. J Med Genet. 2003 May; 40(5):e54. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12746408) Male patients with diagnoses of both breast cancer and prostate cancer. Breast J. 2003 May-Jun; 9(3):208-12. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12752629) Complementary medicine use among women enrolled in a genetic testing program. Cancer Epidemiol Biomarkers Prev. 2003 Apr; 12(4):321-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12692106) Mothers depression in early childhood increases the risk of adolescent anxiety and depression. Evid Based Ment Health. 2003 Feb; 6(1):15. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12588821) Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2002 View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12464649) Social consequences of children's Dec; 27(8):689-98. View in: Oncol. 2002 Nov 15; 20(22):4485-92. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12431973) Complementary and alternative medicine use among women with breast cancer. J Clin Oncol. 2002 Sep 15; population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing. Genet Med. 2002 Sep-Oct; 4(5):346-52. View in: hereditary colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high Cancer Res. Jul 15; 62(14):3925-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12124320) Evaluation of microsatellite instability for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res. 2002 Jun 15; 62(12):3485-92. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12067992) Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol. 2002 Jun 01; J Med. 2002 May 23; 346(21):1616-22. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12023993) Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study. J Clin Oncol. 2002 Apr 15; 20(8):2085-91. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11956269) Depressive spectrum disorders in high-risk adolescents: episode duration and predictors of time to recovery. J Am Acad Child Adolesc Psychiatry. 2002 Apr; in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11860059) by a missense mutation associated with Li-Fraumeni Syndrome. Cancer Res. 2001 Nov 15; 61(22):8062-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11719428) Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics. 2001 Oct; 11(7):635-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11668223) Genetic susceptibility 2001 [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11498834) BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res. 2001 Jul 15; 61(14):5420-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11454686) Tubal ligation and risk in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet. 2001 May application of psychometric and associations 2001 Apr; 29(2):165-75. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11321631) Germ-line p53 mutations predispose to wide spectrum early-onset cancers. Cancer Epidemiol Biomarkers Prev. 2001 Feb; 10(2):83-7. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11219776) The relation of daily stressors to somatic and emotional symptoms in children with and without recurrent abdominal pain. J Consult Clin Psychol. 2001 Feb; al.: familial breast cancer: an investigation into the outcome of treatment for early stage disease. Fam Cancer. 2001; 1(2):73-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/14574000) Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Res. 2000 Dec 15; 60(24):6859-63. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11156380) Disclosure of familial genetic information: perceptions of the duty to inform. Am J Med. 2000 Dec 15; 109(9):705-11. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11137485) Laboratory and performance-based measures of depression in children and adolescents. J Clin Child Psychol. 2000 Dec; 29(4):509-25. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11126630) Long-term Semin radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol. 2000 Oct 01; 18(19):3360-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11013276) Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and 2000 Sep; the gene I1307K mutation in Ashkenazi Jewish patients with Aug 16; 284(7):857-60. View in: ovarian kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10. Genes Chromosomes Cancer. 2000 Jul; 28(3):300-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10862036) Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. 2000 May; peers with somatic symptoms: the impact of gender, stress, and illness. Psychol. 2000 Apr-May; 25(3):125-35. pubertal timing: maternal depression, stepfather presence, and marital and family stress. Child Dev. 2000 Mar-Apr; 71(2):485-501. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10834479) Docetaxel administered on a weekly metastatic J Clin Oncol. 2000 Mar; 18(6):1212-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10715290) Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int. Feb; 66(2):100-3. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10652955) Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor. Genes Chromosomes Cancer. 2000 Feb; 27(2):124-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10612799) Behavioral risk factors among women presenting for genetic testing. Cancer Epidemiol Biomarkers Prev. Dec 24; in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10617473) Case Report-Loyalty, Legacy, and Ledger: Contextual Therapy in a Patient with a Family History of Ovarian Cancer. J Genet Couns. 1999 Dec; 8(6):359-72. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26140826) Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet. 1999 Nov 27; 354(9193):1846-50. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10584720) A 40-year-old woman with a strong family history of breast cancer. JAMA. 1999 Nov 24; 282(20):1953-60. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10580462) Germ-line msh6 1999 Oct 15; 59(20):5068-74. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10537275) Breast cancer risk after bilateral oophorectomy in BRCA1 mutation carriers. J Sep 01; 91(17):1475-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10469748) Privacy in research. Science. 1999 Aug 27; 285(5432):1359-61. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10490410) Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical 282(3):247-53. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10422993) p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome. Oncogene. 1999 Jul 08; 18(27):3970-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10435620) The impact of a brief coping skills intervention on adherence to breast self-examination among first-degree relatives of newly diagnosed breast cancer patients. Psychooncology. 1999 May-Jun; 8(3):220-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10390734) Modification cancer risk by the polymorphic androgen-receptor CAG repeat. J View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10205268) Alternative intrathecal pain. 1999 Apr; 2(2):85-91. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22151112) Benefits of colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med. 1998 Nov 15; 129(10):787-96. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9841584) Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates. Calcif Tissue mothers' and children's reports of somatic and emotional symptoms in patients with recurrent abdominal pain or emotional disorders. J Abnorm Child Psychol. 1998 Oct; 26(5):381-91. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9826296) Germline in PTEN are an infrequent cause of genetic predisposition to breast cancer. Oncogene. 1998 Aug 13; 17(6):727-31. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9715274) Family predictors of suicidal symptoms adolescents. J Adolesc. 1998 Aug; 21(4):445-57. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9757409) Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol. 1998 Jul; 16(7):2417-25. View in: pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet. 1998 Jun; 62(6):1381-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9585613) Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol. 1998 Jun; 16(6):2045-51. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9626202) Genetic testing for susceptibility to cancer. Task Force on Cancer Genetics Education. JAMA. 1998 May 27; 279(20):1612-3. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9613907) Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. J Natl Cancer Inst. 90(10):761-6. View in: 1998 May; 16(5):1639-41. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9586872) Multiple primary in families with Li-Fraumeni syndrome. J Natl Cancer Inst. 1998 Apr 15; in: 1998 Mar; [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9521431) The impact of a brief problem-solving training intervention for relatives of recently diagnosed breast cancer patients. Ann Behav Med. 1998; 20(1):7-12. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9755346) Genetic counseling and testing for cancer susceptibility: do women PTH antagonist on serum calcium and PTH levels in hypercalcemic Calcif Tissue Int. 1997 Dec; 61(6):455-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9383271) The American Society of Clinical Oncology position on genetic testing: implications for health care providers: workshop no. 4. Cancer. 1997 Aug 01; 80(3 Suppl):632-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11657063) Validation of family history of breast cancer and identification of the BRCA1 and other syndromes using a population-based cancer registry. J Health. 6(3):349-51. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9201670) Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med. 1997 May 336(20):1465-71. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9164232) for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA. 1997 Mar 26; 277(12):997-1003. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9091675) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA. 1997 Mar 19; 277(11):915-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9062331) pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med. 1996 Nov 07; 335(19):1413-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8875917) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med. 1996 Nov; 2(11):1179-83. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8898735) Genetic heterogeneity in hereditary breast role of and BRCA2. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8751855) \"First do no harm\" also applies to cancer susceptibility testing. Cancer J Sci Am. 1996 Sep-Oct; 2(5):250-2. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9166540) Testing for inherited Jun 275(24):1928-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8648875) Jun 08; 347(9015):1631. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8667903) Display rules for anger, sadness, and pain: it depends on who is watching. Child Dev. 1996 Jun; 67(3):957-73. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8706538) BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet. 1996 May; 13(1):123-5. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8673091) Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med. 1996 Jan 18; 334(3):143-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8531968) A test of the cognitive diathesis-stress model of depression in children: academic stressors, attributional style, perceived competence, and control. J Soc Aug; 69(2):370-80. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7643310) Cognitions stress: direct and moderating effects on depressive versus externalizing symptoms during the junior high school transition. J Abnorm Psychol. 1995 Aug; 104(3):453-63. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7666282) Do parents excuse the misbehavior of children with physical or emotional symptoms? An investigation of the pediatric sick role. J 1995 Jun; 20(3):329-45. View loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer. Clin Cancer Res. 1995 May; 1(5):539-44. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9816013) Testing for cancer genes: Nat Med. 1995 Apr; 1(4):302-3. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7585056) Long-term health outcomes in patients with recurrent abdominal pain. J Pediatr Psychol. 1995 Apr; 20(2):233-45. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7760222) Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet. 1995 Mar; 56(3):608-15. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7887414) Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA. 1995 Feb 15; 273(7):577-85. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7837392) Ethical, social and counselling issues cancer susceptibility. Cancer Surv. 1995; 25:381-97. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8718528) An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995 Jan; 56(1):254-64. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7825586) Genetic analysis of eight breast-ovarian cancer families with BRCA1 mutations. Monogr. 1995; [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8573462) in pediatric patients: a prospective study of the role of negative life events, child social and academic competence, and parental somatic symptoms. J Consult Clin Psychol. 1994 Dec; 62(6):1213-21. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7860819) Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet. 1994 Dec; 8(4):387-91. View in: human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1994 Apr 08; 77(1):1 p following 166. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8156592) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993 Dec 03; 75(5):1027-38. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8252616) Screening children at Pediatr. 1993 Dec; 5(6):712-5. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8124424) Family history and breast cancer. Probabilities and possibilities. JAMA. 1993 Oct 06; 270(13):1602-3. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8371474) Psychosocial correlates of recurrent childhood pain: a comparison of pediatric patients with recurrent abdominal pain, organic illness, and psychiatric disorders. J Abnorm Psychol. 1993 May; 102(2):248-58. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8315137) Gene for breast and cancer. Lancet. 1993 Apr 24; 341(8852):1060-1. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8096963) Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA. 1993 Apr 21; 269(15):1970-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8352830) Cognitions, depressive Psychol. 1993 Feb; 102(1):47-57. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8436699) Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J Natl Cancer Inst. 1992 Aug 05; 84(15):1156-60. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1635084) Screening for germ line TP53 mutations in breast cancer patients. Cancer Res. 1992 Jun 01; 52(11):3234-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1591732) Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med. 1992 May 14; 326(20):1309-15. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1565144) Follow-up study of twenty-four Res. 1991 Nov [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1681381) symptoms in pediatric abdominal pain patients: relation to chronicity of abdominal pain and parent somatization. Abnorm Child Psychol. 1991 Aug; 19(4):379-94. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1757708) What specificity designs say causality in research? Psychol Bull. 1991 Jul; 110(1):129-36. Dec 15; 66(12):2658-60. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2249207) Melanoma and soft tissue sarcoma patients. Cancer. 1990 Dec 01; 66(11):2432-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2245401) Comprehensive management of disseminated breast Cancer. 1990 Sep 15; 66(6 Suppl):1439-48. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2205375) Recurrent abdominal pain in children: psychiatric diagnoses and parental psychopathology. J Am Acad Child Adolesc Psychiatry. 1990 Jul; 29(4):648-56. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2387802) Improving first appointment attendance rates in child psychiatry outpatient clinics. J Am Acad Child Adolesc Psychiatry. 1990 Jul; 29(4):657-60. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2387803) Adjuvant systemic therapy for patients with node-negative tumors. Cancer. 1990 May 01; 65(9 Suppl):2132-47. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2183925) The value 1990 Apr; 8(4):574-5. Jan 20; 335(8682):176-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1967474) of chemotherapy in cancer. Clin diffuse bone marrow metastases and associated leukemoid reaction. A case report and brief literature review. Am J Clin Pathol. 1988 Dec; 90(6):723-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3057863) a J View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3343206) immunologic infection with human immunodeficiency virus: implications for immunologic classification of the disease. Proc Natl Acad Sci U S A. 1987 Aug; 84(15):5404-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3496603) Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users. AIDS. 1987 Jul; 1(2):105-11. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2896511) AIDS and self-organization among intravenous Addict. 1987 Mar; 22(3):201-19. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3583474) Ectopic bone formation in children and adolescents with head injuries: its management. J Pediatr Orthop. 1987 Jan-Feb; 7(1):83-90. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3098781) A stage of HTLV-III in users. NIDA Res Monogr. 67:328-34. View Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York. N Engl J Med. 1984 Aug 16; 311(7):467-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6087140) Waldenstr\u00f6m's macroglobulinemia and autoimmune disease in a family. Ann Intern Med. 1980 Dec; 93(6):830-2. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6778280) Universal versus personal helplessness 89(1):56-66. View simple for splicing the common bile duct into the duodenum of "}